S&P ASX All Technology

3,075.00

0.00%

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Kos Pharmaceuticals (KOSP)
Kos Pharmaceuticals (KOSP) News

KOSP

Kos (KOSP)

Kos Pharmaceuticals

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:KOSP

1 2 3 Next >>

Date	Time	Source	Headline	Symbol	Company
14/12/2006	01:22	PR Newswire (US)	Abbott Acquires a Majority of Shares of Kos Pharmaceuticals, Inc.	NASDAQ:KOSP	Kos Pharmaceuticals
05/12/2006	07:36	PR Newswire (US)	Abbott's Acquisition of Kos Pharmaceuticals, Inc. Clears Antitrust Review	NASDAQ:KOSP	Kos Pharmaceuticals
15/11/2006	05:45	PR Newswire (US)	Abbott Laboratories Commences Tender Offer for All Outstanding Shares of Kos Pharmaceuticals, Inc.	NASDAQ:KOSP	Kos Pharmaceuticals
09/11/2006	23:00	Business Wire	Kos Reports a 17% Increase in Revenue, Earnings Per Share of $0.71, and Solid Cash Flow from Operations	NASDAQ:KOSP	Kos Pharmaceuticals
08/11/2006	03:21	PR Newswire (US)	Holland & Knight Leads Kos Pharmaceuticals, Inc. Buyout by Abbott Laboratories for $3.7 Billion	NASDAQ:KOSP	Kos Pharmaceuticals
06/11/2006	23:50	PR Newswire (US)	Abbott to Expand Presence in Lipid Management Market With Acquisition of Kos Pharmaceuticals	NASDAQ:KOSP	Kos Pharmaceuticals
04/11/2006	01:31	Business Wire	Kos to Report Third Quarter Results on November 9, 2006 Conference Call at 8:30 A.M. ET	NASDAQ:KOSP	Kos Pharmaceuticals
22/09/2006	06:41	Business Wire	Kos Announces Positive Overall Results for Two Phase III Trials of Icatibant for the Treatment of Hereditary Angioedema	NASDAQ:KOSP	Kos Pharmaceuticals
19/09/2006	21:00	Business Wire	Kos to Present at the UBS Global Life Sciences Conference	NASDAQ:KOSP	Kos Pharmaceuticals
19/09/2006	00:05	Business Wire	Kos Pharmaceuticals Announces Compliance with NASDAQ Continued Listing Requirements	NASDAQ:KOSP	Kos Pharmaceuticals
06/09/2006	22:30	PR Newswire (US)	SkyePharma and Mundipharma Announce Exclusive Licence Agreement for Marketing and Distribution of Flutiform(TM) in Europe	NASDAQ:KOSP	Kos Pharmaceuticals
17/08/2006	06:15	Business Wire	Kos Announces Notice from Nasdaq Regarding Potential Delisting	NASDAQ:KOSP	Kos Pharmaceuticals
10/08/2006	02:42	PR Newswire (US)	Arisaph Pharmaceuticals Announces Second Closing of $8 Million Equity Investment	NASDAQ:KOSP	Kos Pharmaceuticals
08/08/2006	21:00	Business Wire	Kos Reports 25% Increase in Revenue, Solid Financial Results and Progress in Research and Development	NASDAQ:KOSP	Kos Pharmaceuticals
28/07/2006	00:26	Business Wire	Kos to Report Second Quarter Results on August 8, 2006 Conference Call at 8:30 a.m. ET	NASDAQ:KOSP	Kos Pharmaceuticals
26/07/2006	00:39	Business Wire	Kos Reports Summary Results from Clinical Study on Benefits of Combining Aspirin with Optimized Niaspan(R) CF	NASDAQ:KOSP	Kos Pharmaceuticals
13/07/2006	00:18	Business Wire	Kos Submits Supplemental New Drug Application To FDA For New Niaspan(R) CF Range of Products	NASDAQ:KOSP	Kos Pharmaceuticals
20/06/2006	16:00	Business Wire	Niaspan(R) Combined with Low/Moderate Dosed Statin Achieves Better Total Lipid Control vs. Higher Dose Statin Monotherapy or Zo	NASDAQ:KOSP	Kos Pharmaceuticals
07/06/2006	23:42	Business Wire	Kos Announces Completion of Patient Randomization for Jerini's Phase III Clinical Trials of Icatibant for the Subcutaneous Trea	NASDAQ:KOSP	Kos Pharmaceuticals
09/05/2006	21:00	Business Wire	Kos Reports Continued Double Digit Increase in Revenue, Financial Results in Line with Guidance and Authorization for up to 7 M	NASDAQ:KOSP	Kos Pharmaceuticals
08/05/2006	22:00	PR Newswire (US)	SkyePharma and Kos to Host Teleconference Today on US Marketing and Distribution Agreement for Flutiform(TM)	NASDAQ:KOSP
08/05/2006	17:00	PR Newswire (US)	SkyePharma and Kos Announce Exclusive Licence Agreement for Marketing and Distribution of Flutiform(TM) in the United States	NASDAQ:KOSP	Kos Pharmaceuticals
06/05/2006	00:51	Business Wire	CORRECTING and REPLACING Kos Announces Presentation at the Bank of America 2006 Healthcare Conference	NASDAQ:KOSP	Kos Pharmaceuticals
05/05/2006	22:30	Business Wire	Kos Announces Presentation at the Bank of America 2006 Healthcare Conference	NASDAQ:KOSP	Kos Pharmaceuticals
26/04/2006	03:09	Business Wire	Kos Announces Presentation at the Deutsche Bank 2006 Healthcare Conference	NASDAQ:KOSP	Kos Pharmaceuticals
25/04/2006	07:06	Business Wire	Kos Pharmaceuticals to Report First Quarter Results on May 9, 2006 Conference Call at 8:30 A.M. ET	NASDAQ:KOSP	Kos Pharmaceuticals
20/04/2006	00:25	Business Wire	Kos Announces Annual Shareholders Meeting April 27, 2006	NASDAQ:KOSP	Kos Pharmaceuticals
13/04/2006	04:51	Business Wire	Centers for Medicare and Medicaid Services (CMS) Advises Plans Niaspan(R) is Now a Part D Eligible Drug; Confirms Niaspan as an	NASDAQ:KOSP	Kos Pharmaceuticals
02/03/2006	00:36	Business Wire	Kos Announces Presentation at the Lehman Brothers Ninth Annual Global Healthcare Conference	NASDAQ:KOSP	Kos Pharmaceuticals
01/03/2006	00:52	Business Wire	Kos Announces Presentation at the SG Cowen 26th Annual Health Care Conference	NASDAQ:KOSP	Kos Pharmaceuticals